New T47D Breast Cancer Cell Lines for the Independent Study of Progesterone B- and A-Receptors: Only Antiprogestin-occupied B-Receptors Are Switched to Transcriptional Agonists by cAMP

Cancer Research

Volumn 54, Issue 14, 1994, Pages 3868-3877

  Miller, Louise A ^a   Groshong, Steve D ^b   Takimoto, Glenn S ^a   Horwitz, Kathryn B ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b Molecular Biology Program ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA (4 ACETYLPHENYL) 17BETA HYDROXY 17ALPHA (1 PROPYNYL)ESTRA 4,9 DIEN 3 ONE; 8 BROMO CYCLIC AMP; ANTIGESTAGEN; CYCLIC AMP; MIFEPRISTONE; ONAPRISTONE; PROGESTERONE; PROGESTERONE RECEPTOR; PROMEGESTONE;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CONTROLLED STUDY; DNA DRUG COMPLEX; DRUG EFFECT; HORMONE RESISTANCE; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR OCCUPANCY; TRANSCRIPTION INITIATION;

BASE SEQUENCE; BREAST NEOPLASMS; CYCLIC AMP; FEMALE; GONANES; HUMANS; MIFEPRISTONE; MOLECULAR SEQUENCE DATA; PROGESTINS; RECEPTORS, PROGESTERONE; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0028026693     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Sartorius, C.A., Tung, L., Takimoto, G.S., and Horwitz, K.B. Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP.J. Biol. Chem., 268: 9262-9266, 1993.
2. Beck, C.A., Weigel, N.L., Moyer, M.L., Nordeen, S.K., and Edwards, D.P. The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways. Proc. Natl. Acad. Sci. USA, 90: 4441-4445, 1993.
3. Nordeen, S.K., Bona, B.J., and Moyer, M.L. Latent agonist activity of the steroid antagonist, RU486, is unmasked in cells treated with activators of protein kinase A. Mol. Endocrinol., 7: 731-742, 1993.
4. Schrader, W.T., and O'Malley, B.W. Progesterone-binding components of chick oviducts. Characterization of purified subunits. J. Biol. Chem., 247: 51-59, 1972.
5. Horwitz, K.B., and Alexander, P.S. In situ photolinked nuclear progesterone receptors of human breast cancer cells: subunit molecular weights after transformation and translocation. Endocrinology, 113: 2195-2201, 1983.
6. Krett, N.L., Wei, L.L., Francis, M.D., Nordeen, S.K., Gordon, D.F., Wood, W.M., and Horwitz, K.B. Human progesterone A-receptors can be synthesized intracellu-larly and are biologically functional. Biochem. Biophys. Res. Commun., 157: 278-285, 1988.
7. Kastner, P., Krust, A., Turcotte, B., Stropp, U., Tora, L., Gronemeyer, H., and Chambon, P. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J., 9: 1603-1614, 1990.
8. Wei, L.L., Gonzalez-Aller, C., Wood, W.M., Miller, L.A., and Horwitz, K.B. 5’-Heterogeneity in human progesterone receptor transcripts predicts a new amino-terminal truncated “C’-receptor and unique A-receptor messages. Mol. Endocrinol., 4: 1833-1840, 1990.
9. Feil, P.D., Clarke, C.L., and Satyaswaroop, P.G. Progesterone receptor structure and protease activity in primary human endometrial carcinoma. Cancer Res., 48: 1143-1149, 1988.
10. Horwitz, K.B., Francis, M.D., and Wei, L.L. Hormone-dependent covalent modification and processing of human progesterone receptors in the nucleus. DNA, 4: 451-460, 1985.
11. Kastner, P., Bocquel, M.T., Turcotte, B., Gamier, J.M., Horwitz, K.B., Chambon, P., and Gronemeyer, H. Transient expression of human and chicken progesterone receptors does not support alternative translational initiation from a single mRNA as the mechanism generating two receptor isoforms. J. Biol. Chem., 265: 12163-12167, 1990.
12. Conneely, O.M., Kettelberger, D.M., Tsai, J.J., Schrader, W.T., and O'Malley, B.W. The chicken progesterone receptor A and B isoforms are products of an alternate translation initiation event. J. Biol. Chem., 264: 14062-14064, 1989.
13. Wei, L.L., Krett, N.L., Francis, M.D., Gordon, D.F., Wood, W.M., O'Malley, B.W., and Horwitz, K.B. Multiple human progesterone receptor messenger ribonucleic acids and their autoregulation by progestin agonists and antagonists in breast cancer cells. Mol. Endocrinol., 2: 62-72, 1988.
14. Horwitz, K.B. The molecular biology of RU486. Is there a role for antiprogestins in the treatment of breast cancer? Endocr. Rev., 13: 146-163, 1992.
15. Umesono, K., and Evans, R.M. Determinants of target gene specificity for steroid/ thyroid hormone receptors. Cell, 57: 1139-1146, 1989.
16. Tora, L., Gronemeyer, H., Turcotte, B., Gaub, M.P., and Chambon, P. The N-terminal region of the chicken progesterone receptor specifies target gene activation. Nature (Lond.), 333: 185-188, 1988.
17. Meyer, M.E., Pornon, A., Ji, J., Bocquel, M.T., Chambon, P., and Gronemeyer, H. Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor. EMBO J., 9: 3923-3932, 1990.
18. Tung., L., Mohamed, K.M., Hoeffler, J.P., Takimoto, G.S., and Horwitz, K.B. Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors. Mol. Endocrinol., 7: 1256-1265, 1993.
19. Jantzen, H.M., Strähle, U., Gloss, B., Stewart, F., Schmid, W., Boshart, M., Miksicek, R., and Shütz, G. Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene. Cell, 49: 29-38, 1987.
20. Cato, A.C.B., Miksicek, R., Shütz, G., Arnemann, J., and Beato, M. The hormone regulatory element of mouse mammary tumour virus mediates progesterone induction. EMBO J., 5: 2237-2240, 1986.
21. Keydar, I., Chen, L., Karbey, S., Weiss, F.R., Delarea, J., Radu, M., Chaitcik, S., and Brenner, H.J. Establishment and characterization of a cell line of human breast carcinoma origin. Eur. J. Cancer, 15: 659-670, 1979.
22. Horwitz, K.B., Mockus, M.B., and Lessey, B.A. Variant T47D human breast cancer cells with high progesterone receptor levels despite estrogen and antiestrogen resistance. Cell, 28: 633-642, 1982.
23. Graham, M.L., II, Smith, J.A., Jewett, P.B., and Horwitz, K.B. Heterogeneity of progesterone receptor content and remodeling by tamoxifen characterize subpopula-tions of cultured human breast cancer cells: analysis by quantitative dual parameter flow cytometry. Cancer Res., 52: 593-602, 1992.
24. El-Ashry, D., Oñate, S.A., Nordeen, S.K., and Edwards, D.P. Structural determinants of a glucocorticoid receptor recognition element. Mol. Endocrinol., 4: 1866-1873, 1989.
25. Cailleau, R., Young, R., Olive, M., and Reeves, W.J., Jr. Breast tumor cell lines from pleural effusions. J. Natl. Cancer Inst., 53: 661-674, 1974.
26. Graham, M.L., II, Dalquist, K.E., and Horwitz, K.B. Simultaneous measurement of progesterone receptors and DNA indices by flow cytometry: analysis of breast cancer cell mixtures and genetic instability of the T47D line. Cancer Res., 49: 3943-3949, 1989.
27. Graham, M.L., II, Bunn, P.A., Jr., Jewett, P.B., Gonzalez-Aller, C., and Horwitz, K.B. Simultaneous measurement of progesterone receptors and DNA indices by flow cytometry: characterization of an assay in breast cancer cell lines. Cancer Res., 49: 3934-3942, 1989.
28. Baneiji, J., Rusconi, S., and Schaffner, W. Expression of β-globin gene is enhanced by remote SV40 DNA sequences. Cell, 27: 299-308, 1981.
29. Estes, P.A., Wei, L.L., Toft, D.O., Sullivan, W.P., Horwitz, K.B., and Edwards, D.P. Immunologic analysis of human breast cancer progesterone receptors. I. Immunoaffinity purification of transformed receptors and production of monoclonal antibodies. Biochemistry, 26: 6250-6262, 1987.
30. Takimoto, G.S., Tasset, D.M., Eppert, A.C., and Horwitz, K.B. Hormone-induced progesterone receptor phosphorylation consists of sequential DNA-independent and DNA-dependent stages: analysis with zinc finger mutants and the progesterone antagonist ZK98299. Proc. Natl. Acad. Sci. USA, 89: 3050-3054, 1992.
31. Law, M.L., Kao, F.T., Wei, Q., Hartz, J.A., Greene, G.L., Zarucki-Schulz, T., Conneely, O.M., Jones, C., Puck, T.T., O'Malley, B.W., and Horwitz, K.B. The progesterone receptor gene maps to human chromosome band 11ql3, the site of the mammary oncogene int-2. Proc. Natl. Acad. Sci. USA 84: 2877-2881, 1987.
32. Sheridan, P.L., Krett, N.L., Gordon, J.A., and Horwitz, K.B. Down-regulation of human progesterone receptors is independent of their nuclear phosphorylation. Mol. Endocrinol., 2: 1329-1342, 1988.
33. Sheridan, P.L., Evans, R.M., and Horwitz, K.B. Phosphotryptic peptide analysis of human progesterone receptors: new phosphorylated sites formed in nuclei after hormone treatment. J. Biol. Chem., 264: 6520-6528, 1989.
34. Sheridan, P.L., Francis, M.D., and Horwitz, K.B. Synthesis of human progesterone receptors in T47D cells: nascent A- and B-receptors are active without a phospho-rylation-dependent post-translational maturation step. J. Biol. Chem., 264: 7054-7058, 1989.
35. Horwitz, K.B., and McGuire, W.L. Nuclear mechanisms of estrogen action: effects of estradiol and antiestrogen on cytoplasmic and nuclear estrogen receptors and nuclear receptor processing. J. Biol. Chem., 253: 8185-8191, 1978.
36. Horwitz, K.B., and McGuire, W.L. Actinomycin D prevents nuclear processing of estrogen receptors. J. Biol. Chem., 253: 6315-6318, 1978.
37. Mockus, M.B., and Horwitz, K.B. Progesterone receptors in human breast cancer: stoichiometric translocation and nuclear receptor processing. J. Biol. Chem., 258: 4778-4783, 1983.
38. Cidlowski, J.A., and Cidlowski, N.B. Regulation of glucocorticoid receptors by glucocorticoids in cultured HeLa S3 cells. Endocrinology, 109: 1975-1982, 1981.
39. Svec, F., and Rudis, M. Glucocorticoids regulate the glucocorticoid receptor in the AtT-20 cell. J. Biol. Chem., 256: 5984-5987, 1981.
40. Burnstein, K.L., Jewell, C.M., and Cidlowski, J.A. Human glucocorticoid receptor cDNA contains sequences sufficient for receptor down-regulation. J. Biol. Chem., 265: 7284-7291, 1990.
41. Alksnis, M., Barkhem, T., Strömstedt, P.E., Ahola, H., Kutoh, E., Gustafsson, J., Poellinger, L., and Nilsson, S. High level expression of functional full length and truncated glucocorticoid receptor in Chinese hamster ovary cells: demonstration of ligand-induced down-regulation of expressed receptor mRNA and protein. J. Biol. Chem., 266: 10078-10085, 1991.
42. Horwitz, K.B., and McGuire, W.L. Estrogen control of progesterone receptor in human breast cancer: correlation with nuclear processing of estrogen receptor. J. Biol. Chem., 253: 2223-2228, 1978.
43. Horwitz, K.B. Is a functional estrogen receptor always required for progesterone receptor induction in breast cancer? J. Steroid Biochem., 15: 209-217, 1981.
44. Graham, M.L., II, Krett, N.L., Miller, L.A., Leslie, K.K., Gordon, D.F., Wood, W.M., Wei, L.L., and Horwitz, K.B. Genetic instability and estrogen receptor mutations: possible elements in the progression of breast cancers to hormone resistance. Cancer Res., 50: 6208-6217, 1990.
45. Wang, Y., and Miksicek, R.J. Identification of a dominant negative form of the human estrogen receptors. Mol. Endocrinol., 5: 1707-1715, 1991.
46. Misrahi, M., Atger, M., d'Auriol, L., Loosfelt, H., Meriel, C., Fridlansky, F., Guiochon-Mantel, A., Galibert, F., and Milgrom, E. Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNA. Biochem. Biophys. Res. Commun., 143: 740-748, 1987.
47. Zajchowski, D.A., Sager, R., and Webster, L. Estrogen inhibits the growth of estrogen-receptor negative, but not estrogen receptor positive, human mammary epithelial cells expressing a recombinant estrogen receptor. Cancer Res., 53: 5004-5011, 1993.
48. Chalbos, D., Vignon, F., Keydar, I., and Rochefort, H. Estrogens stimulate cell proliferation and induce secretory proteins in a human breast cancer cell line (T47D). J. Clin. Endocrinol. Metab., 55: 276-283, 1982.
49. Logeat, F., Pamphile, R., Loosfelt, H., and Milgrom, E. One-step immunoaffinity purification of active progesterone receptor: further evidence in favor of the existence of a single steroid binding subunit. Biochemistry, 24: 1029-1035, 1985.
50. Dorner, A.J., Semler, B.L., Jackson, R.J., Hanecak, R., Duprey, E., and Wimmer, E. In vitro translation of poliovirus RNA: utilization of internal initiation sites in reticulocyte lysate. J. Virol., 50: 507-514, 1984.
51. Quarmby, V.E., Yarbrough, W.G., Lubahn, D.B., French, F.S., and Wilson, E.M. Autologous down-regulation of androgen receptor messenger ribonucleic acid. Mol. Endocrinol., 4: 22-28, 1990.
52. Vegeto, E., Shahbaz, M.M., Wen, D.X., Goldman, M.E., O'Malley, B.W., and McDonnell, D.P. Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Mol. Endocrinol., 7: 1244-1255, 1993.
53. Klein-Hitpass, L., Cato, A.C.B., Henderson, D., and Ryffel, G.U. Two types of antiprogestins identified by their differential action in transcriptionally active extracts from T47D cells. Nucleic Acids Res., 19: 1227-1234, 1991.
54. Bocquel, M.T., Ji, J., Ylikomi, T., Benhanou, B., Vergezac, A., Chambon, P., and Gronemeyer, H. Type II antagonists impair the DNA binding of steroid hormone receptors without affecting dimerization. J. Steroid Biochem. Mol. Biol., 45: 205-215, 1993.
55. Horwitz, K.B. Mechanisms of hormone resistance in breast cancer. Breast Cancer Res. Treat., 26: 119-130, 1993.